Red Cell Partners has publicly launched Trase, a new company offering an agentic platform designed to solve the "last mile" problem of AI adoption in regulated industries. Trase delivers and implements end-to-end AI agent applications and specialized language models, enabling organizations to securely automate complex workflows. In a significant move, Red Cell has appointed Baskar Sridharan, the former Vice President and GM of AI/ML at AWS who oversaw Bedrock and SageMaker, as the President of Trase.
Red Cell Partners launches Trase, an AI agent platform for regulated sectors.
The platform focuses on the "last mile" of AI implementation and deployment.
Trase emerges with $10.5 million in pre-seed funding.
Baskar Sridharan, former AWS AI/ML leader, joins as President.
The company already has clients including Duke Health and the Department of the Navy.
Trase aims to deliver measurable efficiency gains in mission-critical environments.
Trase was built to address the significant hurdles enterprises face when trying to implement AI at scale. The platform provides turnkey autonomous agents and specialized language models that can be deployed on cloud, on-premise, or edge devices. It focuses on delivering practical, operational AI solutions for complex, highly regulated industries like healthcare, defense, and energy. “AI adoption is failing. That’s because implementing AI at scale is exceptionally hard, messy, and its value, to date, has been difficult to prove,” said Grant Verstandig, founder of Red Cell Partners and CEO of Trase. “Trase was built to solve for the last mile of adoption by delivering agentic solutions that enable organizations to successfully deploy AI and unlock its full promise."
The appointment of Baskar Sridharan signals Trase's serious intent to compete at the highest level of enterprise AI. With decades of experience at AWS, Google Cloud, and Microsoft, Sridharan brings unparalleled expertise in building and scaling foundational AI and cloud infrastructure. He emphasized the need for a hands-on approach, stating, “The last mile for successful AI transformation... is about integrating turn-key Agents across data, systems, processes, and human expertise and then deploying them at scale." He further added, “After more than two decades in Big Tech, I’m joining Trase to take on the hard, but necessary work of driving widespread enterprise AI transformation."
With substantial funding, a proven platform already serving high-profile clients, and top-tier leadership, Trase is positioned to make a substantial impact on how regulated industries integrate and benefit from advanced AI. The company’s focus on moving beyond generic AI tools to deliver tailored, deployable agentic solutions addresses a critical gap in the current market.
About Trase
Trase is an agentic platform that delivers and operationalizes end-to-end autonomous Agents and Agent applications at scale. Trase’s initial focus is on complex, highly regulated industries, enabling enterprises in healthcare, national security, and energy to create and deploy autonomous turn-key agents into existing infrastructure in a compliant, safe, secure and cost-effective manner. Visit us at trase.ai and follow us on LinkedIn.
About Red Cell Partners
Red Cell Partners is a venture studio building rapidly scalable technology-led companies that are bringing revolutionary advancements to market in healthcare, cyber, and national security. United by a shared sense of duty and deep belief in the power of innovation, Red Cell is developing powerful tools and solutions to address our Nation’s most pressing problems.